| Potassium Chloride Extended-Release Tablets, USP MICRO-DISPERSIBLE TECHNOLOGY ® | Redpharm Drug | 20260522 | 1 |
| HyVite | Lifsa Drugs LLC | 20260520 | 1 |
| Potassium Chloride Extended-Release Tablets, USP MICRO-DISPERSIBLE TECHNOLOGY ® | Aphena Pharma Solutions - Tennessee, LLC | 20260520 | 4 |
| Potassium Chloride Extended-Release Tablets, USP | Northstar Rx LLC | Ascent Pharmaceuticals, Inc. | 20260518 | 2 |
| Potassium Acetate Injection USP | Hospira, Inc. | Pfizer Healthcare India Private Limited | 20260427 | 10 |
| Potassium Acetate Injection, USP | Hospira, Inc. | Pfizer Healthcare India Private Limited | 20260427 | 10 |
| Potassium Acetate Injection, USP | Hospira, Inc. | Pfizer Healthcare India Private Limited | 20260427 | 8 |
| Potassium Chloride Extended-Release Tablets USP, 10 mEq and 20 mEq Rx only | REMEDYREPACK INC. | 20260423 | 5 |
| Potassium Chloride Extended-Release Tablets USP, 10 mEq and 20 mEq Rx only | Redpharm Drug | 20260415 | 4 |
| These highlights do not include all the information needed to use SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE ORAL SOLUTION safely and effectively. See full prescribing information for SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE ORAL SOLUTION. SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE ORAL SOLUTION Initial U.S. Approval: 2010 | Wilshire Pharmaceuticals, Inc. | 20260413 | 1 |
| POTASSIUM ACETATE Injection, USP | Hospira, Inc. | Pfizer Healthcare India Private Limited | 20260409 | 18 |
| Potassium Chloride Extended-Release Tablets USP, 20 mEq Rx only | Atlantic Biologicals Corp. | 20260330 | 2 |
| These highlights do not include all the information needed to use POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS. POTASSIUM CHLORIDE extended-release tablets, for oral use Initial U.S. Approval: 1948 | Bryant Ranch Prepack | 20260330 | 101 |
| Dexolyte Solution Injection | Clipper | 20260324 | 3 |
| DextroLyte | MWI (VetOne) | 20260324 | 4 |
| Electrolyte Solution with Dextrose | Nova-Tech, Inc. | 20260324 | 3 |
| Electrolyte solution with dextrose | Covetrus | 20260324 | 5 |
| Vetalyte Plus | Aspen Veterinary | 20260324 | 6 |
| Lactated Ringers | Nova-Tech, Inc. | 20260323 | 5 |
| Lactated Ringers | MWI (VetOne) | 20260323 | 4 |
| LACTATED RINGERS | VetTek | 20260323 | 4 |
| Lactated Ringers Injection | A & G Pharmaceuticals, Inc. | 20260323 | 6 |
| Lactated Ringers Injection | Clipper | 20260323 | 3 |
| Lactated Ringers Injection SC | Covetrus | 20260323 | 7 |
| Lactated Ringers Solution | Aspen Veterinary | 20260323 | 4 |
| LytaJect IV | Nova-Tech, Inc | 20260323 | 3 |
| These highlights do not include all the information needed to use POTASSIUM CHLORIDE safely and effectively. See full prescribing information for POTASSIUM CHLORIDE. POTASSIUM CHLORIDE oral solution Initial U.S. Approval: 1948 | Ajenat Pharmaceuticals LLC | 20260323 | 1 |
| Cal Dex CMPK Injection | Aspen Veterinary | 20260320 | 9 |
| Cal-Phos #2 With Potassium Injection | Clipper | 20260320 | 2 |
| CMPK Solution | MWI (VetOne) | 20260320 | 4 |
| POTASSIUM CHLORIDE EXTENDED RELEASE TABLETS, USP 10 mEq K | Bryant Ranch Prepack | 20260311 | 100 |
| POTASSIUM CHLORIDE EXTENDED-RELEASE CAPSULES These highlights do not include all the information needed to use POTASSIUM CHLORIDE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for POTASSIUM CHLORIDE EXTENDED-RELEASE CAPSULES. POTASSIUM CHLORIDE extended-release capsules, for oral use administration Initial U.S. Approval: 1948 | A-S Medication Solutions | 20260223 | 5 |
| Veterinary Lactated Ringers | Assure Infusion Inc | Laboratorios Alfa SRL | 20260223 | 1 |
| Veterinary Hartmann Solution | Assure Infusions Inc | Laboratorios Alfa SRL | 20260222 | 1 |
| POTASSIUM CHLORIDE EXTENDED RELEASE TABLETS, USP 10 mEq K | REMEDYREPACK INC. | 20260217 | 5 |
| These highlights do not include all the information needed to use POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS. POTASSIUM CHLORIDE extended-release tablets, for oral use Initial U.S. Approval: 1948 | REMEDYREPACK INC. | 20260213 | 12 |
| These highlights do not include all the information needed to use POTASSIUM CHLORIDE safely and effectively. See full prescribing information for POTASSIUM CHLORIDE POTASSIUM CHLORIDE Oral Solution Initial U.S. Approval: 1948 | Major Pharmaceuticals | 20260211 | 8 |
| POTASSIUM CHLORIDE EXTENDED RELEASE TABLETS, USP 10 mEq K | Major Pharmaceuticals | 20260204 | 1 |
| POTASSIUM CHLORIDE EXTENDED RELEASE TABLETS, USP 20 mEq K | Major Pharmaceuticals | 20260204 | 1 |
| These highlights do not include all the information needed to use POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS. POTASSIUM CHLORIDE extended-release tablets for oral use Initial U.S. Approval: 1948 | Rising Pharma Holdings, Inc. | Cohance Lifesciences Limited | 20260201 | 7 |
| These highlights do not include all the information needed to use SUFLAVE ® safely and effectively. See full prescribing information for SUFLAVE. SUFLAVE (polyethylene glycol 3350, sodium sulfate, potassium chloride, magnesium sulfate, and sodium chloride for oral solution) Initial U.S. Approval: 2023 | Azurity Pharmaceuticals, Inc. | 20260131 | 1 |
| These highlights do not include all the information needed to use SUPREP BOWEL PREP KIT safely and effectively. See full prescribing information for SUPREP BOWEL PREP KIT. SUPREP BOWEL PREP KIT (sodium sulfate, potassium sulfate, and magnesium sulfate) oral solution Initial U.S. Approval: 2010 | Azurity Pharmaceuticals, Inc. | 20260131 | 1 |
| These highlights do not include all the information needed to use SUTAB ® safely and effectively. See full prescribing information for SUTAB. SUTAB (sodium sulfate, magnesium sulfate, and potassium chloride) tablets, for oral use Initial U.S. Approval: 2020 | Azurity Pharmaceuticals, Inc. | 20260131 | 1 |
| These highlights do not include all the information needed to use POKONZA ® safely and effectively. See full prescribing information for POKONZA ® . POKONZA ® (Potassium chloride oral solution) Initial U.S. Approval: 1948 | Carwin Pharmaceutical Associates, LLC | 20260122 | 1 |
| Potassium Chloride Extended-release Capsules, USP | AvKARE | 20260115 | 9 |
| These highlights do not include all the information needed to use POTASSIUM CHLORIDE ORAL SOLUTION safely and effectively. See full prescribing information for POTASSIUM CHLORIDE ORAL SOLUTION. POTASSIUM CHLORIDE oral solution Initial U.S. Approval: 1948 | Saptalis Pharmaceuticals, LLC | 20260115 | 5 |
| POTASSIUM CHLORIDE oral solution These highlights do not include all the information needed to use POTASSIUM CHLORIDE safely and effectively. See full prescribing information for POTASSIUM CHLORIDE. Initial U.S. Approval: 1948 | AvPAK | 20260109 | 2 |
| Potassium Chloride Extended-Release Tablets, USP 10 mEq, 15 mEq and 20 mEq | Advagen Pharma Ltd. | Rubicon Research Limited | 20260107 | 2 |
| These highlights do not include all the information needed to use POTASSIUM CHLORIDE ORAL SOLUTION safely and effectively. See full prescribing information for POTASSIUM CHLORIDE ORAL SOLUTION. POTASSIUM CHLORIDE oral solution Initial U.S. Approval: 1948 | Advagen Pharma Limited | Rubicon Research Limited | 20260107 | 4 |
| These highlights do not include all the information needed to use POTASSIUM CHLORIDE FOR ORAL SOLUTION safely and effectively. See full prescribing information for POTASSIUM CHLORIDE FOR ORAL SOLUTION. POTASSIUM CHLORIDE for oral solution Initial U.S. Approval: 1948 | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | Strides Pharma Global Pte. Ltd. | Strides Pharma Science Limited | 20260106 | 4 |
| Potassium Chloride Extended-Release Tablets, USP MICRO-DISPERSIBLE TECHNOLOGY ® | Northwind Health Company, LLC | 20260101 | 2 |
| These highlights do not include all the information needed to use POTASSIUM CHLORIDE EXTENDED-RELEASE safely and effectively. See full prescribing information for POTASSIUM CHLORIDE EXTENDED-RELEASE. POTASSIUM CHLORIDE EXTENDED-RELEASE tablets, for oral use Initial U.S. Approval: 1948 | Northwind Health Company, LLC | 20260101 | 2 |
| These highlights do not include all the information needed to use POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS. POTASSIUM CHLORIDE extended-release tablets, for oral use Initial U.S. Approval: 1948 | Northwind Health Company, LLC | 20260101 | 2 |
| These highlights do not include all the information needed to use Potassium Chloride Extended-release Tablets, USP safely and effectively. See full prescribing information for Potassium Chloride Extended-release Tablets, USP. Potassium Chloride Extended-release Tablets, USP for oral use. Initial U.S. Approval: 1948 | Northwind Health Company, LLC | 20260101 | 2 |
| Potassium Chloride Extended-Release Tablets, USP Rx Only These highlights do not include all the information needed to use POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS Initial U.S. Approval: 1948 | Aphena Pharma Solutions - Tennessee, LLC | 20251229 | 1 |
| Potassium Chloride Extended-Release Tablets, USP MICRO-DISPERSIBLE TECHNOLOGY ® | Northwind Health Company, LLC | 20251226 | 2 |
| These highlights do not include all the information needed to use POTASSIUM CHLORIDE safely and effectively. See full prescribing information for POTASSIUM CHLORIDE. POTASSIUM CHLORIDE oral solution Initial U.S. Approval: 1948 | BPI Labs LLC | Ajenat Pharmaceuticals, LLC | 20251226 | 5 |
| Potassium Chloride Extended-release Tablets, USP 10 mEq and 20 mEq | Redpharm Drug | 20251224 | 3 |
| These highlights do not include all the information needed to use POKONZA ® safely and effectively. See full prescribing information for POKONZA ® . POKONZA ® (Potassium Chloride for Oral Solution, USP) Initial U.S. Approval: 1948 | Carwin Pharmaceutical Associates, LLC | 20251218 | 1 |
| POTASSIUM CHLORIDE ORAL SOLUTION These highlights do not include all the information needed to use POTASSIUM CHLORIDE ORAL SOLUTION safely and effectively. See full prescribing information for POTASSIUM CHLORIDE ORAL SOLUTION. POTASSIUM CHLORIDE oral solution Initial U.S. Approval: 1948 | ATLANTIC BIOLOGICALS CORP. | 20251211 | 3 |
| These highlights do not include all the information needed to use POTASSIUM CHLORIDE safely and effectively. See full prescribing information for POTASSIUM CHLORIDE. POTASSIUM CHLORIDE for oral solution Initial U.S. Approval: 1948 | IPG Pharmaceuticals, Inc. | 20251209 | 1 |
| Alka-Seltzer Gold | Bayer HealthCare LLC. | 20251204 | 9 |
| Potassium Chloride Extended-Release Tablets USP, 10 mEq and 20 mEq Rx only | REMEDYREPACK INC. | 20251203 | 3 |
| POTASSIUM CHLORIDE EXTENDED-RELEASE CAPSULES These highlights do not include all the information needed to use POTASSIUM CHLORIDE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for POTASSIUM CHLORIDE EXTENDED-RELEASE CAPSULES. POTASSIUM CHLORIDE extended-release capsules, for oral use administration Initial U.S. Approval: 1948 | Granules India Ltd | 20251202 | 5 |
| POTASSIUM CHLORIDE ORAL SOLUTION These highlights do not include all the information needed to use POTASSIUM CHLORIDE safely and effectively. See full prescribing information for POTASSIUM CHLORIDE. POTASSIUM CHLORIDE oral solution Initial U.S. Approval: 1948 | Granules Pharmaceuticals Inc. | Brio Pharmaceuticals, Inc | 20251202 | 4 |
| Potassium Chloride Extended-Release Tablets USP, 10 mEq and 20 mEq Rx only | Granules India Ltd | 20251201 | 4 |
| These highlights do not include all the information needed to use SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE ORAL SOLUTION safely and effectively. See full prescribing information for SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE ORAL SOLUTION SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE ORAL SOLUTION Initial U.S. Approval: 2010 | Affordable Pharmaceuticals, LLC | 20251130 | 2 |
| These highlights do not include all the information needed to use SUPREP BOWEL PREP KIT safely and effectively. See full prescribing information for SUPREP BOWEL PREP KIT. SUPREP BOWEL PREP KIT (sodium sulfate, potassium sulfate, and magnesium sulfate) oral solution Initial U.S. Approval: 2010 | Braintree Laboratories, Inc. | Braintree Laboratories, Inc.. | 20251130 | 9 |
| Potassium Chloride ER | Direct_Rx | 20251126 | 2 |
| These highlights do not include all the information needed to use POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS. POTASSIUM CHLORIDE extended-release tablets, for oral use Initial U.S. Approval: 1948 | Aphena Pharma Solutions - Tennessee, LLC | 20251124 | 2 |
| These highlights do not include all the information needed to use POTASSIUM CHLORIDE safely and effectively. See full prescribing information for POTASSIUM CHLORIDE. POTASSIUM CHLORIDE oral solution Initial U.S. Approval: 1948 | Aurobindo Pharma Limited | APL HEALTHCARE LIMITED | 20251124 | 1 |
| POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS These highlights do not include all the information needed to use POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS. POTASSIUM CHLORIDE extended-release tablets, for oral use Initial U.S. Approval: 1948 | REMEDYREPACK INC. | 20251121 | 1 |
| Potassium Chloride Extended-Release Capsules, USP | AvPAK | 20251119 | 6 |
| Potassium Chloride Extended-Release Tablets, USP Rx Only | Aphena Pharma Solutions - Tennessee, LLC | 20251119 | 3 |
| These highlights do not include all the information needed to use POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS.POTASSIUM CHLORIDE extended-release tablets, for oral useInitial U.S. Approval: 1948 | Advagen Pharma Ltd | Rubicon Research Limited | 20251119 | 5 |
| These highlights do not include all the information needed to use POTASSIUM CHLORIDE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for POTASSIUM CHLORIDE EXTENDED-RELEASE CAPSULES. POTASSIUM CHLORIDE extended-release capsules, for oral use Initial U.S. Approval: 1948 | PD-Rx Pharmaceuticals, Inc. | 20251117 | 7 |
| POTASSIUM CHLORIDE EXTENDED-RELEASE CAPSULES These highlights do not include all the information needed to use POTASSIUM CHLORIDE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for POTASSIUM CHLORIDE EXTENDED-RELEASE CAPSULES. POTASSIUM CHLORIDE extended-release capsules, for oral use administration Initial U.S. Approval: 1948 | BluePoint Laboratories | Granules India Ltd | 20251110 | 3 |
| Potassium Chloride Extended-Release Tablets USP, 10 mEq and 20 mEq Rx only | Bluepoint Laboratories | Granules India Ltd | 20251110 | 4 |
| Potassium Chloride | Henry Schein, Inc. | 20251107 | 7 |
| POTASSIUM CHLORIDE EXTENDED RELEASE TABLETS, USP 10 mEq K | Bryant Ranch Prepack | 20251106 | 100 |
| POTASSIUM CHLORIDE EXTENDED RELEASE TABLETS, USP 10 mEq K | Bryant Ranch Prepack | 20251106 | 100 |
| POTASSIUM CHLORIDE EXTENDED RELEASE TABLETS, USP 10 mEq K | Bryant Ranch Prepack | 20251106 | 100 |
| Potassium Chloride Extended-Release Tablets USP, 10 mEq and 20 mEq Rx only | A-S Medication Solutions | 20251106 | 6 |
| Potassium Chloride Extended-Release Tablets USP, 10 mEq and 20 mEq Rx only | A-S Medication Solutions | 20251106 | 6 |
| These highlights do not include all the information needed to use POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS. POTASSIUM CHLORIDE extended-release tablets, for oral use Initial U.S. Approval: 1948 | A-S Medication Solutions | 20251106 | 1 |
| CEO TWO | Beutlich Pharmaceuticals, LLC | Speciality Pharma Manufacturing | 20251105 | 3 |
| These highlights do not include all the information needed to use LACTATED RINGER’S INJECTION safely and effectively. See full prescribing information for LACTATED RINGER’S INJECTION. LACTATED RINGER’S injection , for intravenous use Initial U.S. Approval: 1971 | B. Braun Medical Inc. | 20251105 | 18 |
| These highlights do not include all the information needed to use POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS. POTASSIUM CHLORIDE extended-release tablets, for oral use Initial U.S. Approval: 1948 | A-S Medication Solutions | 20251105 | 3 |
| These highlights do not include all the information needed to use POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS. POTASSIUM CHLORIDE extended-release tablets, for oral use Initial U.S. Approval: 1948 | A-S Medication Solutions | 20251105 | 1 |
| These highlights do not include all the information needed to use RINGER’S INJECTION safely and effectively. See full prescribing information for RINGER’S INJECTION. RINGER’S injection, for intravenous use Initial U.S. Approval: 1971 | B. Braun Medical Inc. | 20251105 | 14 |
| INTRAVENOUS SOLUTIONS with POTASSIUM CHLORIDE | ICU Medical Inc. | Hospira, Inc. | 20251102 | 11 |
| These highlights do not include all the information needed to use MOVIPREP safely and effectively. See full prescribing information for MOVIPREP. MOVIPREP® (polyethylene glycol 3350, sodium sulfate, sodium chloride, potassium chloride, sodium ascorbate, and ascorbic acid for oral solution) Initial U.S. Approval: 2006 | Salix Pharmaceuticals, Inc. | Norgine Limited | 20251031 | 46 |
| NORMOSOL ® -R pH 7.4 | ICU Medical Inc. | 20251030 | 13 |
| Normosol ® -R and 5% Dextrose Injection | ICU Medical Inc. | 20251029 | 13 |
| NORMOSOL™-M and 5% DEXTROSE Injection MULTIPLE ELECTROLYTES AND 5% DEXTROSE INJECTION TYPE 1, USP | ICU Medical Inc. | 20251024 | 11 |
| These highlights do not include all the information needed to use POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS POTASSIUM CHLORIDE EXTENDED-RELEASE tablets, for oral use Initial U.S. Approval: 1948 | Macleods Pharmaceuticals Limited | 20251018 | 1 |
| KLOR-CON ® M Potassium Chloride Extended-Release Tablets, USP MICRO-DISPERSIBLE TECHNOLOGY ® | Cardinal Health 107, LLC | 20251017 | 4 |
| These highlights do not include all the information needed to use POTASSIUM CHLORIDE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for POTASSIUM CHLORIDE EXTENDED-RELEASE CAPSULES. POTASSIUM CHLORIDE extended-release capsules, for oral use Initial U.S. Approval: 1948 | PD-Rx Pharmaceuticals, Inc. | 20251002 | 10 |
| These highlights do not include all the information needed to use POLYETHYLENE GLYCOL-3350, ELECTROLYTES, AND ASCORBATE FOR ORAL SOLUTION safely and effectively. See full prescribing information for POLYETHYLENE GLYCOL-3350, ELECTROLYTES, AND ASCORBATE FOR ORAL SOLUTION. POLYETHYLENE GLYCOL-3350, ELECTROLYTES, AND ASCORBATE FOR ORAL SOLUTION (polyethylene glycol 3350, sodium sulfate, sodium chloride, potassium chloride, sodium ascorbate, and ascorbic acid for oral solution) Initial U.S. Approval: 2006 | Oceanside Pharmaceuticals | Novel Laboratories, Inc. | Norgine Limited | 20251001 | 5 |
| POTASSIUM CHLORIDE EXTENDED-RELEASE CAPSULES These highlights do not include all the information needed to use POTASSIUM CHLORIDE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for POTASSIUM CHLORIDE EXTENDED-RELEASE CAPSULES. POTASSIUM CHLORIDE extended-release capsules, for oral use administration Initial U.S. Approval: 1948 | Granules Pharmaceuticals Inc | Granules India Ltd | 20250930 | 6 |
| Potassium Chloride Extended-Release Tablets USP, 10 mEq and 20 mEq Rx only | Granules Pharmaceuticals Inc. | Granules India Ltd | 20250930 | 8 |
| Potassium Chloride Extended-Release Tablets, USP MICRO-DISPERSIBLE TECHNOLOGY ® | Bryant Ranch Prepack | 20250930 | 104 |
| POTASSIUM CHLORIDE EXTENDED-RELEASE CAPSULES These highlights do not include all the information needed to use POTASSIUM CHLORIDE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for POTASSIUM CHLORIDE EXTENDED-RELEASE CAPSULES. POTASSIUM CHLORIDE extended-release capsules, for oral use administration Initial U.S. Approval: 1948 | REMEDYREPACK INC. | 20250925 | 4 |
| These highlights do not include all the information needed to use POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS. POTASSIUM CHLORIDE extended-release tablets, for oral use Initial U.S. Approval: 1948 | Epic Pharma, LLC | Yichang Humanwell Pharmaceutical Co., Ltd. | Yichang Humanwell Oral Solid Dosage Plant | 20250923 | 6 |
| These highlights do not include all the information needed to use POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS. POTASSIUM CHLORIDE extended-release tablets, for oral use Initial U.S. Approval: 1948 | Major Pharmaceuticals | 20250922 | 4 |
| These highlights do not include all the information needed to use POTASSIUM CHLORIDE ORAL SOLUTION safely and effectively. See full prescribing information for POTASSIUM CHLORIDE ORAL SOLUTION USP. POTASSIUM CHLORIDE oral solution Initial U.S. Approval: 1948 | Macleods Pharmaceuticals Limited | 20250922 | 1 |
| These highlights do not include all the information needed to use POTASSIUM CHLORIDE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for POTASSIUM CHLORIDE EXTENDED-RELEASE CAPSULES. POTASSIUM CHLORIDE extended-release capsules, for oral use Initial U.S. Approval: 1948 | Major Pharmaceuticals | 20250918 | 1 |
| These highlights do not include all the information needed to use POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS. POTASSIUM CHLORIDE extended-release tablets, for oral use Initial U.S. Approval: 1948 | NCS HealthCare of KY, LLC dba Vangard Labs | Yichang Humanwell Pharmaceutical Co,. Ltd. | 20250917 | 1 |
| GaviLyte™-C with Flavor Pack (PEG-3350 (240 g) and Electrolytes for Oral Solution, USP) with flavor pack | Lupin Pharmaceuticals,Inc. | Novel Laboratories, Inc. | 20250910 | 4 |
| Potassium Chloride Extended-Release Tablets USP, 10 mEq and 20 mEq Rx only | Preferred Pharmaceuticals Inc. | 20250910 | 4 |
| These highlights do not include all the information needed to use GaviLyte – N safely and effectively. See full prescribing information for GaviLyte – N GaviLyte™ – N (polyethylene glycol 3350 (420 g), sodium chloride, sodium bicarbonate and potassium chloride for oral solution) Initial U.S. Approval: 1991 | Lupin Pharmaceuticals,Inc. | Novel Laboratories, Inc. | 20250910 | 7 |
| These highlights do not include all the information needed to use GaviLyte™- G safely and effectively. See full prescribing information for GaviLyte™- G. GaviLyte™- G (PEG-3350 (236 g) and Electrolytes for Oral Solution, USP) Initial U.S. Approval:1984 | Lupin Pharmaceuticals,Inc. | Novel Laboratories, Inc. | 20250910 | 9 |
| These highlights do not include all the information needed to use POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS. POTASSIUM CHLORIDE extended-release tablets, for oral use Initial U.S. Approval: 1948 | Preferred Pharmaceuticals Inc. | 20250909 | 4 |
| Potassium Chloride Extended-Release Tablets, USP Rx only | Major Pharmaceuticals | 20250905 | 3 |
| These highlights do not include all the information needed to use POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS. POTASSIUM CHLORIDE extended-release tablets, for oral use Initial U.S. Approval: 1948 | Aphena Pharma Solutions - Tennessee, LLC | 20250904 | 1 |
| These highlights do not include all the information needed to use POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS. POTASSIUM CHLORIDE extended-release tablets, for oral use Initial U.S. Approval: 1948 | Aphena Pharma Solutions - Tennessee, LLC | 20250904 | 1 |
| These highlights do not include all the information needed to use POTASSIUM CHLORIDE FOR ORAL SOLUTION safely and effectively. See full prescribing information for POTASSIUM CHLORIDE FOR ORAL SOLUTION. POTASSIUM CHLORIDE for oral solution Initial U.S. Approval: 1948 | Kesin Pharma Corporation | 20250901 | 1 |
| These highlights do not include all the information needed to use POTASSIUM CHLORIDE EXTENDED-RELEASE safely and effectively. See full prescribing information for POTASSIUM CHLORIDE EXTENDED-RELEASE. POTASSIUM CHLORIDE EXTENDED-RELEASE tablets, for oral use Initial U.S. Approval: 1948 | A-S Medication Solutions | 20250827 | 2 |
| These highlights do not include all the information needed to use POTASSIUM CHLORIDE EXTENDED-RELEASE safely and effectively. See full prescribing information for POTASSIUM CHLORIDE EXTENDED-RELEASE. POTASSIUM CHLORIDE EXTENDED-RELEASE tablets, for oral use Initial U.S. Approval: 1948 | A-S Medication Solutions | 20250827 | 1 |
| RENACARE K Potassium Supplement for Dogs and Cats | Pet Health Pharma, LLC | 20250826 | 1 |